• Establishing clear criteria and governance for diverse patient access pathways, including pre-approval, post-trial, and commercial import requests

• Lessons learned from creating and refining policies to close gaps and support patients

• Strategies for ensuring the longevity and scalability of managed access programmes while adapting to internal and external challenges